For instance, in patients with MetS from the CORDIOPREV study it has been shown that homozygote carriers of the major allele displayed lower plasma insulin levels, lower HOMA-IR (homesotatic model assesment-insulin resistance) and higher insulin sensitivity in response to a low-fat diet than carriers of the minor allele [72]. This evidence concerns the gene INS and metabolic syndrome.